Ignite Creation Date:
2024-05-06 @ 12:42 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01636180
Status:
WITHDRAWN
Last Update Posted:
2015-03-06
First Post:
2012-04-05
Brief Title:
Effect of the Repeated Loading Dose of Clopidogrel and High Dose of Clopidogrel Continuous Therapy on the Platelet Aggregation Inhibition in Patients With Myocardial Infarction Undergoing Interventional Treatment
Sponsor:
Fundacja Ośrodek Badań Medycznych
Organization:
Fundacja Ośrodek Badań Medycznych
Study Overview
Official Title:
Effect of the Repeated Loading Dose of Clopidogrel and High Dose of Clopidogrel Continuous Therapy on the Platelet Aggregation Inhibition in Patients With Myocardial Infarction Undergoing Interventional Treatment
Status:
WITHDRAWN
Status Verified Date:
2015-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REL-0609
Brief Summary:
REL-0609 trials hypothesis is that repeated loading doses of clopidogrel 600 mg administration in addition to high dose of clopidogrel continuous therapy 150 mgday results in higher inhibition of the platelets aggregation in patients with myocardial infarction undergoing interventional treatment comparing to the standard therapy Such treatment strategy will not cause increased risk of bleeding complications In many trials treatment with to repeated loading doses of clopidogrel together with high dose of clopidogrel continuous therapy resulted in MACE reduction improvement of the long term therapy results lower risk of ischemic complications Currently data regarding to the results of the above treatment are still limited
Detailed Description:
The objectives of the study is
to evaluate the effect of the repeated loading dose of clopidogrel 600 mg in addition to high dose of clopidogrel continuous therapy 150 mgday on the platelet aggregation inhibition in patients with myocardial infarction undergoing interventional treatment
to evaluate the safety of the repeated loading dose of clopidogrel 600 mg in addition to high dose of clopidogrel continuous therapy 150 mgday in patients with myocardial infarction undergoing interventional treatment
to evaluate the effect of the repeated loading dose of clopidogrel 600 mg in addition to high dose of clopidogrel continuous therapy 150 mgday on the platelet aggregation inhibition in patients with myocardial infarction undergoing interventional treatment
to evaluate the safety of the repeated loading dose of clopidogrel 600 mg in addition to high dose of clopidogrel continuous therapy 150 mgday in patients with myocardial infarction undergoing interventional treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None